Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population - PubMed (original) (raw)

. 2022 Aug;47(8):1523-1535.

doi: 10.1111/ced.15212. Epub 2022 Jun 1.

Affiliations

Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population

Junfen Zhang et al. Clin Exp Dermatol. 2022 Aug.

Abstract

Background: Studies on the association between severity of atopic dermatitis (AD) and lifestyle factors in adults have not been conducted in the Netherlands to date.

Aim: To explore the association between moderate to severe AD and lifestyle factors in adults in the Dutch general population.

Methods: We conducted this cross-sectional study within the Lifelines Cohort Study by sending a digital AD questionnaire to 135 950 adults in 2020. We extracted data on lifestyle factors from baseline, collected between 2006 and 2013. We analysed the association between lifestyle factors and presence of AD of any severity and of moderate to severe AD, using binary logistic regression and linear regression models.

Results: We enrolled 56 896 participants (mean age 55.8 years, 39.7% males). The lifetime prevalence of self-reported physician-diagnosed AD was 9.1%, and the point prevalence of any AD and of moderate to severe AD was 3.3% and 2.3%, respectively. We found that moderate to severe AD was associated with smoking habit of > 15 pack-years, alcohol consumption of > 2 drinks per day, chronic stress, Class I obesity, and both shorter and longer sleep duration. Moreover, we found dose-response associations with increases in smoking pack-years and level of chronic stress. We observed no associations with abdominal obesity, physical activity, diet quality or a vegetarian/vegan diet.

Conclusion: We found associations between moderate to severe AD and some modifiable lifestyle factors. Our findings indicate that more screening and counselling for lifestyle factors, particularly smoking, alcohol use, stress, obesity and sleep disturbances, appears warranted in patients with moderate to severe AD. Further longitudinal studies are required to better characterize the direction of these associations and to develop strategies for prevention.

© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

PubMed Disclaimer

Conflict of interest statement

MLAS is an advisor, consultant, speaker and/or investigator for AbbVie, Pfizer, LEO Pharma, Regeneron, Sanofi Genzyme, Eli Lilly and Galderma, and has received grants from Regeneron, Sanofi Genzyme, Novartis and Pfizer. The other authors declare that they have no conflict of interest.

Similar articles

Cited by

References

    1. Svensson A, Ofenloch RF, Bruze M et al. Prevalence of skin disease in a population‐based sample of adults from five European countries. Br J Dermatol 2018; 178: 1111–18. - PubMed
    1. Zhang J, Loman L, Voorberg AN et al. Prevalence of adult atopic dermatitis in the general population, with a focus on moderate‐to‐severe disease: results from the Lifelines Cohort Study. J Eur Acad Dermatol Venereol 2021; 35: e787–90. - PubMed
    1. Drucker AM, Wang AR, Li W‐Q et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol 2017; 137: 26–30. - PubMed
    1. Silverberg JI, Garg NK, Paller AS et al. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population‐based study. J Invest Dermatol 2015; 135: 56–66. - PubMed
    1. Kantor R, Kim A, Thyssen JP et al. Association of atopic dermatitis with smoking: a systematic review and meta‐analysis. J Am Acad Dermatol 2016; 75: 1119–25.e1. - PMC - PubMed

MeSH terms

LinkOut - more resources